Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 3 opinions in the last 12 months.
Extendicare Inc., known by the symbol EXE-T, focuses mainly on long-term care (LTC) in Ontario and has shifted away from retirement homes, making its home healthcare division pivotal as it constitutes 50% of its business. The company has shown solid performance this year, particularly within the LTC REIT sector, leading some analysts to suggest that while existing shareholders have benefited, there might be limited potential for further capital gains without a significant market pullback. Investors confident in the home healthcare sector might consider entering once a more favorable price is reached. The comparison with other companies, such as CSH, highlights that EXE requires substantial capital for operations, contrasting with CSH's strategy of divesting lower-return investments. Analysts generally agree on a cautious approach moving forward, indicating that current conditions may not present optimal buying opportunities.
EXE operates long-term care facilities which require a lot of capital, while CSH is more senior homes. CSH has been divesting lower-return investments to become more of a pure-play. You can charge whatever rent in a market if there's no competition. The seniors' population keeps growing. CSH is paying down debt, which was high a few years ago. In CSH, the easy money has been made, though. It could be a keeper, or take profits.
How COVID will effect this industry, retirement homes? He owns Sienna instead. EXE is much more involved in government-funded LTCs. Along with Chartwell, these two companies are under government scrutiny, so they likely do a much better job than private LTCs. Good question how COVID will affect these homes: there may be increased costs to manage the LTCs, and he expects the government to do more oversight, particularly the incompetent LTCs. He prefers Sienna to EXE, because Sienna is a mix of LTCs and retirement homes, while Chartwell is mostly retirement homes, which has more upside but more competitive. Don't buy purely LTCs, like EXE.
Extendicare has a better chart than Chartwell. It has a head-and-shoulder chart movement. If you take into account the general market sell-off, investors need to be forgiving.
Extendicare Inc is a Canadian stock, trading under the symbol EXE-T on the Toronto Stock Exchange (EXE-CT). It is usually referred to as TSX:EXE or EXE-T
In the last year, 3 stock analysts published opinions about EXE-T. 0 analysts recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Extendicare Inc.
Extendicare Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Extendicare Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
3 stock analysts on Stockchase covered Extendicare Inc In the last year. It is a trending stock that is worth watching.
On 2025-04-24, Extendicare Inc (EXE-T) stock closed at a price of $13.29.
Focused on LTC in Ontario, also a home healthcare business just in Ontario (which forms 50% of the business). No longer in retirement homes. If you own it, you've done well; continue to hold and collect the yield now south of 4%. If you have strong view of the home healthcare business, you could dip in at a better entry point.